NASDAQ : KYMR
Kymera Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 126.63 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.81B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Kymera Therapeutics, Inc. (KYMR) reported revenue of 102.23M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 102.23M | 39.21M | 47.07M | 78.59M | 46.83M | 72.83M |
| Cost of Revenue | 429.98M | 316.57M | 240.25M | 189.08M | 164.25M | 137.02M |
| Gross Profit | -327.75M | -277.36M | -193.18M | -110.49M | -117.42M | -64.19M |
| Selling, General & Admin | 77.14M | 68.19M | 63.53M | 55.04M | 43.83M | 36.34M |
| Operating Expenses | 77.14M | 68.19M | 63.53M | 55.04M | 43.83M | 36.34M |
| Operating Income | -404.89M | -345.54M | -256.71M | -165.53M | -161.26M | -100.53M |
| Interest Expense | -302.00K | -370.00K | -249.00K | -196.00K | -176.00K | -175.00K |
| Interest & Investment Income | 55.76M | 38.42M | 38.03M | 18.76M | 6.62M | 488.00K |
| EBT Excluding Unusual Items | -349.43M | -307.50M | -218.93M | -146.96M | -154.81M | -100.22M |
| Asset Writedown | -3.85M | -4.92M | ||||
| Pretax Income | -349.43M | -311.35M | -223.86M | -146.96M | -154.81M | -100.22M |
| Net Income | -349.43M | -311.35M | -223.86M | -146.96M | -154.81M | -100.22M |
| Net Income to Common | -349.43M | -311.35M | -223.86M | -146.96M | -154.81M | -100.22M |
| Shares Outstanding (Basic) | 96.46M | 84.49M | 75.04M | 58.37M | 53.93M | 47.99M |
| Shares Outstanding (Diluted) | 96.46M | 84.49M | 75.04M | 58.37M | 53.93M | 47.99M |
| EPS (Basic) | -3.62 | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 |
| EPS (Diluted) | -3.62 | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 |
| Free Cash Flow | -288.89M | -234.34M | -207.34M | -137.31M | -155.92M | -130.54M |
| Free Cash Flow Per Share | -3.00 | -2.77 | -2.76 | -2.35 | -2.89 | -2.72 |
| Gross Margin | -140.59% | -250.76% | -88.13% | |||
| Operating Margin | -396.04% | -881.24% | -545.36% | -210.62% | -344.37% | -138.03% |
| Profit Margin | -341.79% | -794.04% | -475.56% | -186.99% | -330.60% | -137.60% |
| Free Cash Flow Margin | -282.58% | -597.64% | -440.47% | -174.71% | -332.98% | -179.24% |
| EBITDA | -398.48M | -338.83M | -250.74M | -163.47M | -159.48M | -99.03M |
| EBITDA Margin | -207.99% | -135.97% | ||||
| D&A For EBITDA | 6.41M | 6.71M | 5.97M | 2.06M | 1.78M | 1.50M |
| EBIT | -404.89M | -345.54M | -256.71M | -165.53M | -161.26M | -100.53M |
| EBIT Margin | -210.62% | -138.03% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 373.37M | 357.01M | 120.26M | 109.97M | 68.39M | 47.98M |
| Short-Term Investments | 597.84M | 491.26M | 368.49M | 264.92M | 338.77M | 394.44M |
| Cash & Short-Term Investments | 971.21M | 848.28M | 488.74M | 374.88M | 407.17M | 442.42M |
| Accounts Receivable | 18.76M | 2.54M | 135.00K | |||
| Receivables | 18.76M | 2.54M | 135.00K | |||
| Prepaid Expenses | 27.38M | 22.94M | 21.52M | 11.67M | 9.71M | 8.72M |
| Total Current Assets | 998.59M | 871.21M | 510.27M | 405.32M | 419.42M | 451.27M |
| Property, Plant & Equipment | 78.69M | 85.53M | 97.86M | 101.08M | 22.24M | 21.31M |
| Long-Term Investments | 674.67M | 771.16M | 362.16M | 61.43M | 152.33M | 125.19M |
| Other Long-Term Assets | 15.32M | 14.91M | 7.74M | 7.93M | 9.15M | 8.14M |
| Total Assets | 1.77B | 1.74B | 978.03M | 575.76M | 603.13M | 605.90M |
| Accounts Payable | 11.92M | 4.01M | 5.99M | 7.08M | 4.33M | 4.00M |
| Accrued Expenses | 63.31M | 42.27M | 34.87M | 33.86M | 27.50M | 22.97M |
| Current Portion of Leases | 13.58M | 13.76M | 13.11M | 6.34M | 3.94M | 3.60M |
| Current Unearned Revenue | 22.93M | 13.58M | 37.88M | 35.26M | 61.74M | |
| Other Current Liabilities | 905.00K | 242.00K | 223.00K | 524.00K | 303.00K | 228.00K |
| Total Current Liabilities | 89.72M | 83.21M | 67.77M | 85.69M | 71.34M | 92.54M |
| Long-Term Leases | 63.02M | 68.50M | 74.65M | 78.33M | 13.39M | 14.36M |
| Long-Term Unearned Revenue | 11.44M | 16.77M | 28.00M | 39.30M | ||
| Other Long-Term Liabilities | 248.00K | 66.00K | ||||
| Total Liabilities | 152.74M | 163.15M | 142.42M | 180.79M | 112.98M | 146.27M |
| Common Stock | 9.00K | 8.00K | 7.00K | 6.00K | 6.00K | 5.00K |
| Additional Paid-In Capital | 2.96B | 2.64B | 1.59B | 926.27M | 878.88M | 689.27M |
| Retained Earnings | -1.33B | -1.07B | -754.61M | -530.75M | -383.79M | -228.98M |
| Comprehensive Income & Other | -14.73M | 1.80M | -1.49M | -552.00K | -4.95M | -660.00K |
| Total Common Equity | 1.61B | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
| Shareholders' Equity | 1.61B | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
| Total Liabilities & Equity | 1.77B | 1.74B | 978.03M | 575.76M | 603.13M | 605.90M |
| Total Debt | 76.60M | 82.25M | 87.76M | 84.67M | 17.34M | 17.96M |
| Net Cash (Debt) | 1.57B | 1.54B | 763.14M | 351.64M | 542.16M | 549.64M |
| Net Cash Per Share | 16.27 | 18.19 | 10.17 | 6.02 | 10.05 | 11.45 |
| Filing Date Shares Outstanding | 85.37M | 81.64M | 64.94M | 61.11M | 55.18M | 51.67M |
| Total Common Shares Outstanding | 85.33M | 81.32M | 64.89M | 55.59M | 55.04M | 51.50M |
| Working Capital | 908.87M | 788.00M | 442.50M | 319.63M | 348.07M | 358.73M |
| Book Value Per Share | 18.92 | 19.42 | 12.88 | 7.11 | 8.91 | 8.93 |
| Tangible Book Value | 1.61B | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
| Tangible Book Value Per Share | 18.92 | 19.42 | 12.88 | 7.11 | 8.91 | 8.93 |
| Machinery | 16.55M | 15.77M | 14.75M | 6.74M | 5.80M | 4.02M |
| Leasehold Improvements | 43.26M | 42.99M | 44.01M | 7.80M | 7.80M | 7.74M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -349.43M | -311.35M | -223.86M | -146.96M | -154.81M | -100.22M |
| Depreciation & Amortization | 8.11M | 8.31M | 7.37M | 3.56M | 2.98M | 2.40M |
| Loss (Gain) From Sale of Assets | 18.00K | |||||
| Asset Writedown & Restructuring Costs | 3.86M | 3.86M | 4.92M | |||
| Loss (Gain) From Sale of Investments | -8.71M | -8.88M | -13.98M | -5.23M | 889.00K | 5.81M |
| Stock-Based Compensation | 68.23M | 59.90M | 55.01M | 43.12M | 35.48M | 24.97M |
| Change in Accounts Receivable | 947.00K | 17.82M | -16.23M | -2.40M | 1.30M | |
| Change in Accounts Payable | 6.42M | -1.97M | -307.00K | 2.04M | 253.00K | 54.00K |
| Change in Unearned Revenue | -37.24M | 20.79M | -41.08M | -8.61M | -37.77M | -69.36M |
| Change in Other Net Operating Assets | 25.05M | -4.50M | -403.00K | 25.48M | 2.30M | 6.08M |
| Operating Cash Flow | -287.56M | -232.89M | -194.50M | -102.83M | -153.09M | -128.95M |
| Capital Expenditures | -1.33M | -1.45M | -12.84M | -34.48M | -2.84M | -1.60M |
| Investment in Securities | -414.23M | -519.61M | -391.24M | 174.37M | 23.36M | -98.24M |
| Investing Cash Flow | -415.56M | -521.06M | -404.08M | 139.89M | 20.52M | -99.83M |
| Long-Term Debt Repaid | -1.49M | -1.58M | -76.00K | -1.13M | -849.00K | |
| Net Debt Issued (Repaid) | -1.72M | -1.49M | -1.58M | -76.00K | -1.13M | -849.00K |
| Issuance of Common Stock | 1.01B | 1.04B | 638.79M | 4.27M | 154.30M | 251.53M |
| Other Financing Activities | -40.70M | -51.90M | -28.36M | -174.00K | -397.00K | |
| Financing Cash Flow | 963.97M | 990.71M | 608.85M | 4.19M | 153.00M | 250.28M |
| Net Cash Flow | 260.85M | 236.76M | 10.27M | 41.25M | 20.43M | 21.50M |
| Free Cash Flow | -288.89M | -234.34M | -207.34M | -137.31M | -155.92M | -130.54M |
| Free Cash Flow Margin | -282.58% | -597.64% | -440.47% | -174.71% | -332.98% | -179.24% |
| Free Cash Flow Per Share | -3.00 | -2.77 | -2.76 | -2.35 | -2.89 | -2.72 |
| Levered Free Cash Flow | -164.68M | -136.04M | -126.83M | -97.62M | -90.21M | -58.30M |
| Unlevered Free Cash Flow | -164.49M | -135.81M | -126.68M | -97.49M | -90.10M | -58.19M |
| Cash Interest Paid | 241.00K | 312.00K | 206.00K | 162.00K | 179.00K | 158.00K |
| Change in Working Capital | -5.77M | 15.27M | -23.97M | 2.68M | -37.62M | -61.92M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 10.87B | 6.22B | 2.61B | 1.41B | 1.37B | 3.26B |
| Enterprise Value | 9.31B | 5.33B | 1.78B | 1.06B | 790.55M | 2.67B |
| Last Close Price | 126.63 | 77.81 | 40.23 | 25.46 | 24.96 | 63.49 |
| Forward PE | 34.27 | 34.27 | 34.27 | 34.27 | 34.27 | |
| PS Ratio | 106.57 | 158.75 | 55.35 | 17.98 | 29.25 | 44.75 |
| PB Ratio | 6.69 | 3.94 | 3.12 | 3.58 | 2.79 | 7.09 |
| P/TBV Ratio | 6.75 | 3.94 | 3.12 | 3.58 | 2.79 | 7.09 |
| EV/Sales Ratio | 91.22 | 135.93 | 37.87 | 13.47 | 16.88 | 36.61 |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.10 | 0.21 | 0.04 | 0.04 |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -0.91 | -0.89 | -1.11 | -1.20 |
| Net Debt / EBITDA Ratio | 3.94 | 4.54 | 3.04 | 2.15 | 3.40 | 5.55 |
| Net Debt / FCF Ratio | 5.43 | 6.56 | 3.68 | 2.56 | 3.48 | 4.21 |
| Asset Turnover | 0.07 | 0.03 | 0.06 | 0.13 | 0.08 | 0.13 |
| Quick Ratio | 10.82 | 10.19 | 7.21 | 4.59 | 5.74 | 4.78 |
| Current Ratio | 11.13 | 10.47 | 7.53 | 4.73 | 5.88 | 4.88 |
| Return on Equity (ROE) | -27.29% | -25.78% | -36.38% | -33.21% | -32.60% | -26.96% |
| Return on Assets (ROA) | -17.64% | -15.88% | -20.65% | -17.55% | -16.67% | -11.50% |
| Return on Capital Employed (ROCE) | -24.10% | -20.80% | -28.20% | -33.80% | -30.30% | -19.60% |
| Earnings Yield | -2.84% | -5.00% | -8.59% | -10.40% | -11.30% | -3.08% |
| FCF Yield | -2.65% | -3.77% | -7.96% | -9.72% | -11.39% | -4.01% |
| Buyback Yield / Dilution | -17.58% | -12.59% | -28.58% | -8.22% | -12.39% | -176.60% |